Insights

What three “no regret” moves should medtech companies make today?

Ganesh Vedarajan and Kelly Tousi

Medtech customers are changing fast, yet at the same time, these customers appear to be standing still. Irrespective of the pace at which their customers are changing, medtech still has to develop and operationalize new business models for the few customers who are buying differently. This puts a strain on SG&A spending for most medtech companies, just as most senior executives are grappling with the task of cutting down costs to fund investments intended to “future-proof” their organizations.

A key question on executives’ minds today is, “How can we fund the investments required for the future while the profitability of our existing businesses is under serious pressure?”

Get expert insights from ZS’s medtech leaders.



Related Videos


Medtech Customer’s Evolution



Disruptive Forces



Optimizing SG&A


Investing in Analytics




Enhance Pricing/Contracting



 

> Read Article